While Gal-9 is recognized as a valuable biomarker for assessing the severity of various other diseases, including autoimmune disorders, viral infections, cancer, and parasitic invasions, its specific function and significance in Chagas disease remain to be determined. This evidence concerns the gene LGALS9 and cancer.